Hybrid diffuse optics could revolutionize blood flow monitoring in critical care

Red blood cell transfusions (RBCTs) are life-saving treatments for critically ill patients suffering from anemia, a condition where the body lacks enough healthy red blood cells to deliver oxygen effectively.

ALK eyes label expansion after Phase III trial success – Pharmaceutical Technology

ALK plans to seek label expansion to include paediatric patients, with an expected paediatric launch in 2025. Image Credit: Sharomka / Shutterstock. ALK’s Itulatek, a

October 12, 2023

During the pandemic, were great vaccines bad business? A company-by-company review

It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people and brought the world to its knees. A key factor

March 25, 2024

New clinical trial aims to extend survival for bile duct cancer patients

A new clinical trial, sponsored by UCL and UCLH, aims to extend survival for some patients with cancer in the biliary tract by treating them

January 17, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.